BioSpace News Archive

Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today on the progress of the Company, recent milestones, financial position, R&D activities and forecast till the end of 2020 and into 2021, as the Company prepares for entering clinical development for its lead pr

Masimo (NASDAQ: MASI) today announced that its management is scheduled to present in the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 at 4:40 p.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the audiocast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a global medical t

Caribou Biosciences, Inc., a leading CRISPR genome editing company, today announced the appointment of Cherry Thomas, MD, as Senior Vice President of Clinical Development. In this newly created position, Dr. Thomas will serve as Caribou’s clinical leader and oversee the advancement of the Company’s first allogeneic CAR-T cell therapy candidate, expected to start clinical trials later this year. “The experience and e

What’s New: Intel Labs and the Perelman School of Medicine at the University of Pennsylvania are co-developing technology to enable a federation of 29 international healthcare and research institutions led by Penn Medicine to train artificial intelligence models that identify brain tumors using a privacy-preserving technique called federated learning.

Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report first quarter 2020 financial results for the period ended March 31, 2020, following the close of the market on Thursday, May 28, 2020.

ABL applies its expertise in custom manufacturing virus-based therapeutics to accelerate the Institut Pasteur and Themis’ coalition COVID-19 vaccine development [11-May-2020] VIENNA , and STRASBOURG, France , May 11, 2020 /PRNewswire/ -- Themis , a clinical-stage biopharmaceutical company focused on immunomodulation therapies for infectious diseases and cancer, and

COVID-19 has altered the way we live our lives and, every day, Canadians are facing new challenges during this crisis.

The American Society for Preventive Cardiology (ASPC) is collaborating with INTERVENT International (INTERVENT) to provide its members and their patients free access to INTERVENT’s evidence-based, personalized, online/digital, educational resources and content.

VisionCare, Inc. (“VisionCare”), a developer of advanced visual prosthetic devices for the treatment of age-related macular degeneration (AMD), today announced that receipt of a Conformité Européene (CE) Mark for the Tsert-SI™ delivery system for the CentraSight treatment program

Aspenstate has received clearance for their portable x-ray system, AiRTouch, from the U.S. Food and Drug Administration (FDA).